Anavex Life Sciences Corp reports results for the quarter ended in December - Earnings Summary

Anavex Life Sciences

07/02/2024 14:45

* Anavex Life Sciences Corp  AVXL.OQ  reported a quarterly
adjusted loss of 11 cents​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -17 cents.  The mean expectation of
two analysts for the quarter was for a loss of 14 cents per
share. Wall Street expected results to range from -15 cents
to -14 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Anavex Life Sciences Corp's reported EPS for the quarter
was a
loss of 11 cents​.
    * The company reported a quarterly loss of $8.62 million.
    * Anavex Life Sciences Corp shares had fallen by 37.8% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 9.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Anavex Life
Sciences Corp is $39.00 
This summary was machine generated from LSEG data February 7 at
02:45 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.14          -0.11          Beat
 Sep. 30 2023      -0.15          -0.12          Beat
 Jun. 30 2023      -0.17          -0.14          Beat
 Mar. 31 2023      -0.19          -0.17          Beat